NZ601980A - Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same - Google Patents

Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same

Info

Publication number
NZ601980A
NZ601980A NZ601980A NZ60198011A NZ601980A NZ 601980 A NZ601980 A NZ 601980A NZ 601980 A NZ601980 A NZ 601980A NZ 60198011 A NZ60198011 A NZ 60198011A NZ 601980 A NZ601980 A NZ 601980A
Authority
NZ
New Zealand
Prior art keywords
proteins
protein
seq
immune response
vaccine
Prior art date
Application number
NZ601980A
Other languages
English (en)
Inventor
Anna Rosander
Marit Pringle
Original Assignee
Anna Rosander
Marit Pringle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anna Rosander, Marit Pringle filed Critical Anna Rosander
Publication of NZ601980A publication Critical patent/NZ601980A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ601980A 2010-01-28 2011-01-28 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same NZ601980A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29896010P 2010-01-28 2010-01-28
US36098610P 2010-07-02 2010-07-02
PCT/SE2011/050090 WO2011093783A1 (en) 2010-01-28 2011-01-28 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same

Publications (1)

Publication Number Publication Date
NZ601980A true NZ601980A (en) 2014-08-29

Family

ID=44319584

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ601980A NZ601980A (en) 2010-01-28 2011-01-28 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same

Country Status (10)

Country Link
US (1) US8703432B2 (enExample)
EP (1) EP2528939B1 (enExample)
JP (1) JP2013518563A (enExample)
CN (1) CN102918053A (enExample)
AU (1) AU2011209988A1 (enExample)
BR (1) BR112012018840A2 (enExample)
CA (1) CA2825282A1 (enExample)
NZ (1) NZ601980A (enExample)
RU (1) RU2012137304A (enExample)
WO (1) WO2011093783A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010423B2 (en) 2013-03-15 2018-07-03 Avinash Kumar Anatomical humeral fixation system and method
JP5740062B1 (ja) 2013-07-03 2015-06-24 三菱化学フーズ株式会社 毛状疣贅病の予防および／または治療方法
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
MX2020005104A (es) * 2017-11-17 2020-12-10 Hipra Scient S L U Composiciones de vacuna para uso contra dermatitis digital en un mamifero.
KR102177180B1 (ko) * 2020-05-13 2020-11-10 순천대학교 산학협력단 신규 트레포네마 파지데니스 균주 및 이의 분리 방법
KR102177181B1 (ko) * 2020-05-14 2020-11-10 순천대학교 산학협력단 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534526A1 (en) * 1991-09-25 1993-03-31 Duphar International Research B.V Treponema hyodysenteriae vaccine
IL103530A0 (en) * 1991-10-25 1993-03-15 Duphar Int Res Treponema hyodysenteriae vaccine
US6287575B1 (en) 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US6096323A (en) * 1997-10-03 2000-08-01 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
CA2825282A1 (en) 2011-08-04
EP2528939B1 (en) 2015-04-08
US20130034560A1 (en) 2013-02-07
EP2528939A1 (en) 2012-12-05
JP2013518563A (ja) 2013-05-23
EP2528939A4 (en) 2013-07-03
CN102918053A (zh) 2013-02-06
RU2012137304A (ru) 2014-03-10
BR112012018840A2 (pt) 2017-06-20
US8703432B2 (en) 2014-04-22
WO2011093783A1 (en) 2011-08-04
AU2011209988A1 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX342291B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
DK2280721T3 (da) Indoleamin-2, 3-dioxygenasebaseret immunterapi
JP2010516290A5 (enExample)
WO2015024667A8 (en) Method for increasing expression of rna-encoded proteins
MY156286A (en) Human il-23 antigen binding proteins
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
EP4421177A3 (en) Prefusion rsv f proteins and their use
JP2011250797A5 (enExample)
EP2562183A8 (en) Novel immunogenic epitopes for immunotherapy
WO2010044889A3 (en) Torque teno virus (ttv) isolates and compositions
NZ713461A (en) Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
WO2012069568A3 (en) Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
JP2015529678A5 (enExample)
NZ601980A (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
JP2014502961A5 (enExample)
UA112747C2 (uk) Лікарський засіб і спосіб профілактики інфікування віл, профілактики і лікування захворювань, що викликаються віл або асоційовані з віл, у тому числі сніду
RU2015106916A (ru) Полипептиды clostridium difficile в виде вакцины
MX2012004448A (es) Clones infecciosos de torque teno virus.
JP2015529677A5 (enExample)
JP2013518563A5 (enExample)
WO2013171661A3 (en) Adjuvant formulations and methods

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2016 BY LEA SKYLLERSTEDT

Effective date: 20150923

LAPS Patent lapsed